The Boeing Company and Subsidiaries

Consolidated Statements of Cash Flows

(Unaudited)

Twelve months ended
December 31

(Dollars in millions)

2018

2017

Cash flows – operating activities:

Net earnings

$10,460

$8,458

Adjustments to reconcile net earnings to net cash provided by operating activities:

Non-cash items – 

Share-based plans expense

202

202

Depreciation and amortization

2,114

2,047

Investment/asset impairment charges, net

93

113

Customer financing valuation (benefit)/expense

(3)

2

(Gain)/loss on dispositions, net

(75)

(21)

Other charges and credits, net

247

293

Changes in assets and liabilities – 

Accounts receivable

(795)

(840)

Unbilled receivables

(1,826)

(1,600)

Advances and progress billings

2,636

4,700

Inventories

568

(1,403)

Other current assets

98

(19)

Accounts payable

2

130

Accrued liabilities

1,117

335

Income taxes receivable, payable and deferred

(180)

656

Other long-term liabilities

87

94

Pension and other postretirement plans

(153)

(582)

Customer financing, net

120

1,041

Other

610

(260)

Net cash provided by operating activities

15,322

13,346

Cash flows – investing activities:

Property, plant and equipment additions

(1,722)

(1,739)

Property, plant and equipment reductions

120

92

Acquisitions, net of cash acquired

(3,230)

(324)

Contributions to investments

(2,607)

(3,569)

Proceeds from investments

2,898

3,607

Purchase of distribution rights

(69)

(131)

Other

(11)

6

Net cash used by investing activities

(4,621)

(2,058)

Cash flows – financing activities:

New borrowings

8,548

2,077

Debt repayments

(7,183)

(953)

Contributions from noncontrolling interests

35

Stock options exercised

81

311

Employee taxes on certain share-based payment arrangements

(257)

(132)

Common shares repurchased

(9,000)

(9,236)

Dividends paid

(3,946)

(3,417)

(11,722)

(11,350)

Effect of exchange rate changes on cash and cash equivalents, including restricted

(53)

80

Net (decrease) / increase in cash & cash equivalents, including restricted

(1,074)

18

Cash & cash equivalents, including restricted, at beginning of year

8,887

8,869

Cash & cash equivalents, including restricted, at end of period

7,813

8,887

Less restricted cash & cash equivalents, included in Investments

176

74

Cash and cash equivalents at end of period

$7,637

$8,813